BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29716871)

  • 1. Therapeutic effect evaluation of reteplase on acute pulmonary embolism.
    Wang W; Zhao X; Ren Y; Qiao P
    Pak J Pharm Sci; 2018 May; 31(3):899-905. PubMed ID: 29716871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical efficacy and safety of thrombolytic treatment with reteplase in patients with intermediate-risk acute pulmonary embolism].
    Zhao HG; Wang SX; Lu ZN; Yan XX; Lyu ZC; Peng FH; Wu Y; Gao X; Hua L; Jing ZC; Xu XQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Apr; 45(4):314-317. PubMed ID: 28545283
    [No Abstract]   [Full Text] [Related]  

  • 3. Reteplase: a review of its use in the management of thrombotic occlusive disorders.
    Simpson D; Siddiqui MA; Scott LJ; Hilleman DE
    Am J Cardiovasc Drugs; 2006; 6(4):265-85. PubMed ID: 16913828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. GUSTO-III Investigators. Global Use of Strategies to Open Occluded Coronary Arteries.
    Gurbel PA; Serebruany VL; Shustov AR; Bahr RD; Carpo C; Ohman EM; Topol EJ
    J Am Coll Cardiol; 1998 Jun; 31(7):1466-73. PubMed ID: 9626821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism.
    Tebbe U; Graf A; Kamke W; Zahn R; Forycki F; Kratzsch G; Berg G
    Am Heart J; 1999 Jul; 138(1 Pt 1):39-44. PubMed ID: 10385761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy evaluation of reteplase in a novel canine acute pulmonary thromboembolism model developed by minimally invasive surgery and digital subtraction angiography.
    Zhang Y; Liu H; Zhang Y; Wu Q; Zhang Y; Zhang J; Zhou X; Jiao H; Fan F; Xue Q; Wang X; Zhong Z
    Drug Des Devel Ther; 2018; 12():3717-3730. PubMed ID: 30464403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of transthoracic echocardiography in therapy regimens evaluation in pulmonary embolism.
    Zhu L; Wang C; Yang Y; Wu Y; Zhai Z; Dai H; Pang B; Tong Z
    J Thromb Thrombolysis; 2008 Dec; 26(3):251-6. PubMed ID: 17705052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spotlight on reteplase in thrombotic occlusive disorders.
    Simpson D; Siddiqui MA; Scott LJ; Hilleman DE
    BioDrugs; 2007; 21(1):65-8. PubMed ID: 17263591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators.
    Bode C; Smalling RW; Berg G; Burnett C; Lorch G; Kalbfleisch JM; Chernoff R; Christie LG; Feldman RL; Seals AA; Weaver WD
    Circulation; 1996 Sep; 94(5):891-8. PubMed ID: 8790022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety Evaluation on Arterial Thrombolysis in Treating Acute Cerebral Infarction.
    Shen B; Liu Q; Gu Y; Wang Y; Zhang Z
    Cell Biochem Biophys; 2015 Nov; 73(2):297-304. PubMed ID: 27352315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current clinical use of reteplase for thrombolysis. A pharmacokinetic-pharmacodynamic perspective.
    Martin U; Kaufmann B; Neugebauer G
    Clin Pharmacokinet; 1999 Apr; 36(4):265-76. PubMed ID: 10320949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of platelet aggregation during thrombolytic treatment of massive pulmonary embolism.
    Mühl D; Füredi R; Gecse K; Ghosh S; Falusi B; Bogár L; Roth E; Lantos J
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):661-7. PubMed ID: 17890954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of reteplase for the treatment of acute arterial occlusion: complexity of underlying lesion predicts outcome.
    Hanover TM; Kalbaugh CA; Gray BH; Langan EM; Taylor SM; Androes MP; Jones WT; Blackhurst DW
    Ann Vasc Surg; 2005 Nov; 19(6):817-22. PubMed ID: 16228804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of massive pulmonary embolism with reteplase.
    Çoner A; Çiçek D; Balcıoğlu S; Akıncı S; Müderrisoğlu H
    Turk Kardiyol Dern Ars; 2018 Mar; 46(2):143-146. PubMed ID: 29512616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant tissue plasminogen activator in patients with pulmonary embolism: correlation of fibrinolytic specificity and efficacy.
    Vaughan DE; Goldhaber SZ; Kim J; Loscalzo J
    Circulation; 1987 Jun; 75(6):1200-3. PubMed ID: 3105914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial.
    Goldhaber SZ; Kessler CM; Heit JA; Elliott CG; Friedenberg WR; Heiselman DE; Wilson DB; Parker JA; Bennett D; Feldstein ML
    J Am Coll Cardiol; 1992 Jul; 20(1):24-30. PubMed ID: 1607532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of reteplase for thrombolysis of hemodialysis catheters at a community and academic regional medical center.
    Hyman G; England M; Kibede S; Lee P; Willets G
    Nephron Clin Pract; 2004; 96(2):c39-42. PubMed ID: 14988596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial.
    Lincoff AM; Califf RM; Van de Werf F; Willerson JT; White HD; Armstrong PW; Guetta V; Gibler WB; Hochman JS; Bode C; Vahanian A; Steg PG; Ardissino D; Savonitto S; Bar F; Sadowski Z; Betriu A; Booth JE; Wolski K; Waller M; Topol EJ;
    JAMA; 2002 Nov; 288(17):2130-5. PubMed ID: 12413372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke.
    Qureshi AI; Ali Z; Suri MF; Kim SH; Shatla AA; Ringer AJ; Lopes DK; Guterman LR; Hopkins LN
    Neurosurgery; 2001 Jul; 49(1):41-8; discussion 48-50. PubMed ID: 11440458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patency trials with reteplase (r-PA): what do they tell us?
    Bode C; Nordt TK; Peter K; Smalling RW; Runge MS; Kübler W
    Am J Cardiol; 1996 Dec; 78(12A):16-9. PubMed ID: 8990406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.